Daily Newsletter

30 August 2023

Share with colleague
Subscribe

Daily Newsletter

30 August 2023

Share with colleague
Subscribe

Spotlight

Talkiatry launches psychiatry services in five more US states

The company aims to address the rising rates of anxiety, depression and suicidality in young people.

Latest news

WhiteFlag turns to StartEngine to raise funds for mental health app

WhiteFlag intends to use the funds from the fundraising campaign to enhance its app features and grow its user base.

30 August 2023

Fortis Healthcare acquires Medeor Hospital in India for $27.23m

The company entered a deal with the VPS Group to buy the hospital earlier this year.

30 August 2023

Stride Treglown to file plans for Singleton Hospital extension

The health board had identified an 'urgent' need to set up a dedicated PET-CT Scanning Unit at the hospital.

30 August 2023

MSF completely resumes services at Haiti’s Tabarre Hospital

The hospital provides medical care for traumatic injuries and severe burns and has an emergency department.

30 August 2023

Zamil AC wins $202m hospital contract in Jeddah

The contract was awarded by Al Muhammadiyah Hospital for Healthcare Company.

30 August 2023

Apollo expands connected care programme across India

The aim is to create an integrated healthcare ecosystem by collaborating with hospitals and nursing homes in urban and rural areas.

30 August 2023

NHS expands blood pressure checks in local communities

High-street pharmacies have enabled over 149,000 blood pressure checks to individuals above 40 in May 2023.

30 August 2023

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.